Table 1.

Inclusion and exclusion criteria

Inclusion criteria	Planned primary surgery for suspected or verified primary breast malignancy
	Age ≥ 18 years
	Signed informed consent
Exclusion criteria	Planned neoadjuvant therapy
	On-going pregnancy
	Iodinated contrast agent allergy
	Renal disease or abnormal S-creatinin (normal range 45–90 μmol/l)
	Untreated thyrotoxicosis (including multinodular goitre) (upon suspicion check P-thyrotropin level, exclusion if < 0.4 mIE/l)
	Severe heart failure
	Myastenia gravis
	Breast implant
	Local recurrence as index lesion
	Inability to understand oral or written information about the study